Cancer is the second leading cause of death globally, trailing only heart disease. In the
United States alone, 1.9 million new cancer cases and 609,360 deaths were recorded for …

Aberrant glycans are a hallmark of cancer states. Notably, emerging evidence has
demonstrated that the diagnosis of cancers with tumour-specific glycan patterns holds great …

This editorial highlights the limitations of preclinical models in accurately reflecting the
complexity of anxiety and depression, which leads to a lack of effective treatments for these …

Genomic instability consists of a range of genetic alterations within the genome that
contributes to tumor heterogeneity and drug resistance. It is a well-established characteristic …

Toxicology is traditionally divided between human and eco-toxicology. In the shared pursuit
of environmental health, this separation does not account for discoveries made in the …

Xenoestrogens and phytoestrogens are referred to as “foreign estrogens” that are produced
outside of the human body and have been shown to exert estrogen-like activity …

Delivering drugs to tumors using nanoparticles (NPs) has shown promising potential in
promoting targeted drug delivery of antineoplastic agents to enhance their efficiency while …

Cancer is an unprecedented proliferation of cells leading to abnormalities in differentiation
and maturation. Treatment of primary and metastatic cancer is challenging. In addition to …

Background Accumulating studies have reported that chronic exposure to ambient fine
particulate matter (PM 2.5) can lead to adverse effects on lung cancer mortality; however …

A high level of homocysteine (Hcy) is associated with oxidative/ER stress, apoptosis, and
impairment of angiogenesis, whereas hydrogen sulfide (H2S) has been found to reverse this …